🇺🇸 cefdinir (Omnicef) in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 10
Most-reported reactions
- Abortion Missed — 1 report (10%)
- Computerised Tomogram Thorax Abnormal — 1 report (10%)
- Cytomegalovirus Viraemia — 1 report (10%)
- Device Related Infection — 1 report (10%)
- Klebsiella Bacteraemia — 1 report (10%)
- Lower Respiratory Tract Infection — 1 report (10%)
- Lung Infiltration — 1 report (10%)
- Maternal Exposure During Pregnancy — 1 report (10%)
- Pneumonia — 1 report (10%)
- Pneumonia Bacterial — 1 report (10%)
Other Infectious Disease approved in United States
Frequently asked questions
Is cefdinir (Omnicef) approved in United States?
cefdinir (Omnicef) does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for cefdinir (Omnicef) in United States?
Abbott is the originator. The local marketing authorisation holder may differ — check the official source linked above.